240 results on '"Tan, Shuguang"'
Search Results
2. Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2
3. Identification of HPV-E7 specific TCRs for tumor immunotherapy
4. KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
5. De novo design of protein interactions with learned surface fingerprints
6. Avian influenza viruses suppress innate immunity by inducing trans-transcriptional readthrough via SSU72
7. An engineered bispecific human monoclonal antibody against SARS-CoV-2
8. Cross-species recognition of SARS-CoV-2 to bat ACE2
9. Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients
10. Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
11. Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
12. Crystal structure of the African swine fever virus core shell protein p15
13. Characterization of CD8 + T cells in immune-privileged organs of ZIKV-infected Ifnar1 −/− mice
14. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5
15. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
16. Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
17. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
18. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
19. The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
20. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients
21. N‐glycosylation of PD‐1 promotes binding of camrelizumab
22. Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses
23. CTL immunogenicity of Rv3615c antigen and diagnostic performances of an ESAT-6/CFP-10/Rv3615c antigen cocktail for Mycobacterium tuberculosis infection
24. Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions
25. Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans
26. Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
27. The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
28. Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
29. Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study
30. Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
31. Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
32. Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
33. Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors
34. The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets
35. De novodesign of site-specific protein interactions with learned surface fingerprints
36. Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection
37. PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy
38. Wilms tumor 1 (WT1)抗原HLA-A11限制性T细胞表位鉴定及特异性TCR筛选
39. Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer.
40. Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation
41. Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
42. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
43. An unexpected similarity between antibiotic-resistant NDM-1 and beta-lactamase II from Erythrobacter litoralis
44. Identification of NY-ESO-1157–165 Specific Murine T Cell Receptors With Distinct Recognition Pattern for Tumor Immunotherapy
45. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry
46. Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies
47. Cross-species recognition of SARS-CoV-2 to bat ACE2
48. Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes
49. Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes
50. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.